Trusted by:
Since older adults have been more severely affected by acute COVID-19, researchers have hypothesized that older adults may have worse long COVID symptoms as well.
A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), which affect millions of people worldwide. The research results were recently published in the international edition of the renowned journal Angewandte Chemie.
Since older adults have been more severely affected by acute COVID-19, researchers have hypothesized that older adults may have worse long COVID symptoms as well. But according to new research published in the Annals of Neurology, an official journal of the American Neurological Association, Northwestern Medicine researchers found on an average of 10 months after COVID-19 onset, younger (ages 18-44) and middle-aged (ages 45-64) adults had worse neurologic symptoms of long COVID than adults 65 and older. Symptoms included headache, numbness and tingling, problems with smell and taste, blurred vision, depression, anxiety, insomnia, fatigue and a decrease in cognitive function. These symptoms occurred regardless of if the patient had mild or severe COVID-19 infections.
KRICT researchers have unveiled groundbreaking LOHC materials that dramatically boost hydrogen storage and release rates, transforming hydrogen into a safer, more transportable energy source.
Patients with lumbar spinal stenosis, a common cause of lower back pain in older adults, may benefit from minimally invasive lumbar decompression. Patients receiving the procedure reported significant reductions in pain, along with better physical function and no decrease in mobility or quality of life. The investigators’ abstract received a Resident/Fellow Travel award from the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) and will be presented at the upcoming 23rd Annual Pain Medicine Meeting in Las Vegas, NV.
Mobile health applications can be powerful tools for tracking patients’ health and reducing hospital visits. However, patients are more likely to sign up for these apps if a clinician or research assistant enrolls them during an in-person visit. This is just one aspect of a broader research project evaluating mobile health apps in relation to spine injection outcomes. The investigators’ abstract received Best of Meeting and Resident/Fellow Travel awards from the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) and will be presented at the upcoming 23rd Annual Pain Medicine Meeting in Las Vegas, NV.
Veterans with fibromyalgia experienced significant improvements in pain, sleep, mood, and overall health in a study looking at a procedure called cranial electrotherapy stimulation. The study found an association between the procedure and specific brain activity that could support management of chronic pain without drugs. The investigators’ abstract received a Best of Meeting award from the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) and will be presented at the upcoming 23rd Annual Pain Medicine Meeting in Las Vegas, NV.
A new study has quantified the risk for whale-ship collisions worldwide for four blue, fin, humpback and sperm whales. Researchers report that global shipping traffic overlaps with about 92% of these whale species’ ranges. Only about 7% of areas at highest risk for whale-ship collisions have measures in place to protect whales.
The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.
Rutgers researchers at the Brain Health Institute (BHI) and Center for Advanced Human Brain Imaging Research (CAHBIR) have uncovered how different types of brain cells work together to form large-scale functional networks in the human brain – interconnected systems that support everything from sensory processing to complex decision-making – paving the way for new insights into brain health and disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
